The plasma therapy market consists of revenues generated by the companies that are engaged in selling and manufacturing plasma therapy products and related services. Plasma therapy is a technique where high concentrations of plasma are transfused or injected to patients to facilitate the healing process. Plasma therapy is frequently used for facial rejuvenation, androgenetic alopecia, and wound healing among others.
The global plasma therapy market is expected to grow from $187.67 million in 2019 to $246.95 million in 2020 at a compound annual growth rate (CAGR) of 31.6%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat a growing number of cases. The use of convalescent plasma collected from individuals who have recovered from COVID-19 is one investigational treatment being explored for COVID-19. The market is then expected to stabilize and grow at a CAGR of 5.7% to reach 291.6 million in 2023.
